SOPHiA GENETICS $234 million IPO and $20 million private placement
We advised SOPHiA GENETICS on its IPO, Nasdaq listing and concurrent private placement
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
ChargePoint Holdings $282 million secondary offering
We advised the underwriters on the stock offering
First Advantage $439.9 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Century Therapeutics $242.7 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Codere Online business combination with DD3 Acquisition Corp. II
We are advising Codere Online on its combination with a SPAC
Jamf $281 million follow-on offering
We advised the underwriters on the SEC-registered stock offering
TaskUs $303.6 million IPO
We advised the underwriters on the IPO and Nasdaq listing
ImmunityBio $500 million at-the-market offering
We advised the sales agent in connection with the equity offering
UiPath $1.54 billion IPO
We advised the underwriters on the IPO and NYSE listing
Americo Life $400 million senior notes offering
We advised the initial purchasers on the investment-grade notes offering